Transcriptomic profiling of Prostate Cancer
This study included primary tumor sequencing data from 197 patients with prostate cancer. All of them did not receive neoadjuvant therapy. Patients belong to the Caucasoid population. For each specimen, extensive information is provided, namely, clinical and pathological criteria, as well as molecular subtype and biochemical relapse status. Overall design: mRNA and miRNA profiles of primary tumors for patients with prostate cancer